Search Results - "Burke, Sandra E."

Refine Results
  1. 1

    Zotarolimus (ABT-578) eluting stents by Burke, Sandra E., Kuntz, Richard E., Schwartz, Lewis B.

    Published in Advanced drug delivery reviews (03-06-2006)
    “…Drug-eluting stents have revolutionized the field of interventional cardiology and have provided a significant innovation for preventing coronary artery…”
    Get full text
    Journal Article
  2. 2

    Oral bimoclomol elevates heat shock protein 70 and reduces myocardial infarct size in rats by Lubbers, Nathan L, Polakowski, James S, Wegner, Craig D, Burke, Sandra E, Diaz, Gilbert J, Daniell, Katina M, Cox, Bryan F

    Published in European journal of pharmacology (18-01-2002)
    “…Bimoclomol has been shown to increase an inducible member of the heat shock protein 70 family (HSP70) and cytoprotect in vitro. Here, we addressed whether oral…”
    Get full text
    Journal Article
  3. 3

    Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks by Garcia-Touchard, Arturo, Burke, Sandra E., Toner, John L., Cromack, Keith, Schwartz, Robert S.

    Published in European heart journal (01-04-2006)
    “…Aims The addition of drug elution to coronary stents plays an integral role in coronary restenosis prevention. The present study was undertaken to determine…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Selective Antagonism of the ETA Receptor Reduces Neointimal Hyperplasia After Balloon-Induced Vascular Injury in Pigs by Burke, Sandra E, Lubbers, Nathan L, Gagne, Gerard D, Wessale, Jerry L, Dayton, Brian D, Wegner, Craig D, Opgenorth, Terry J

    Published in Journal of cardiovascular pharmacology (01-07-1997)
    “…Balloon angioplasty has become an important intervention in clinical cardiology; however, the technique is associated with a high incidence of restenosis,…”
    Get full text
    Journal Article
  6. 6

    Neointimal Formation After Balloon-Induced Vascular Injury in Yucatan Minipigs is Reduced by Oral Rapamycin by Burke, Sandra E, Lubbers, Nathan L, Chen, Yung-Wu, Hsieh, Gin C, Mollison, Karl W, Luly, Jay R, Wegner, Craig D

    Published in Journal of cardiovascular pharmacology (01-06-1999)
    “…Rapamycin, a macrolide antibiotic known to prevent allograft rejection, is a potent inhibitor of cell proliferation. Therefore we studied the effects of orally…”
    Get full text
    Journal Article
  7. 7

    Evaluation of tissue perfusion in a rat model of hind-limb muscle ischemia using dynamic contrast-enhanced magnetic resonance imaging by Luo, Yanping, Mohning, Kurt M., Hradil, Vincent P., Wessale, Jerry L., Segreti, Jason A., Nuss, Merrill E., Wegner, Craig D., Burke, Sandra E., Cox, Bryan F.

    Published in Journal of magnetic resonance imaging (01-09-2002)
    “…Purpose To evaluate the feasibility of using dynamic contrast‐enhanced magnetic resonance imaging (MRI) for assessment of muscle perfusion in a rat model of…”
    Get full text
    Journal Article
  8. 8

    Protection of ischemic cat myocardium by CGS-13080, a selective potent thromboxane A2 synthesis inhibitor by Burke, S E, DiCola, G, Lefer, A M

    Published in Journal of cardiovascular pharmacology (01-09-1983)
    “…A specific inhibitor of thromboxane A2 (TxA2) synthesis, CGS-13080, was studied during acute myocardial ischemia (MI) in cats. To define more clearly the…”
    Get more information
    Journal Article
  9. 9

    Cardiotonic agents. 6. Synthesis and inotropic activity of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones: ring-contracted analogs of imazodan (CI-914) by Sircar, Ila, Morrison, Glenn C, Burke, Sandra E, Skeean, Richard, Weishaar, Ronald E

    Published in Journal of medicinal chemistry (01-10-1987)
    “…A series of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones was synthesized and evaluated for positive inotropic activity. Only compounds with two…”
    Get full text
    Journal Article
  10. 10

    Evidence for Vasoconstriction Mediated by the Endothelin-B Receptor in Domestic Swine by Burke, Sandra E, Nelson, Richard A, Lubbers, Nathan L, Ford, TaLesha T, Fu, Kai I, Padley, Robert J, Wegner, Craig D, Cox, Bryan F

    Published in Journal of cardiovascular pharmacology (01-06-2000)
    “…Endothelin-1 (ET-1), a potent vasoactive and mitogenic peptide, has been implicated in a number of cardiovascular diseases, including congestive heart failure,…”
    Get full text
    Journal Article
  11. 11

    Endothelin-Receptor Antagonist FR 139317 Reduces Infarct Size in a Rabbit Model When Given Before, But Not After, Coronary Artery Occlusion by Burke, Sandra E, Nelson, Richard A

    Published in Journal of cardiovascular pharmacology (01-01-1997)
    “…SUMMARYEndothelins are potent vasoactive peptides that exist as isoforms having different affinities for two main receptor subtypes, ETA and ETB. Based on…”
    Get full text
    Journal Article
  12. 12

    Synthesis and biological activity of 4-(diphenylmethyl)-.alpha.-[(4-quinolinyloxy)methyl]-1-piperazineethanol and related compounds by Sircar, Ila, Haleen, Steve J, Burke, Sandra E, Barth, Hubert

    Published in Journal of medicinal chemistry (01-11-1992)
    “…A series of 4-(diphenylmethyl)-alpha-[(4-quinolinyloxy)methyl]-1-pipe razineethanol and closely related compounds was synthesized and evaluated for cardiac and…”
    Get full text
    Journal Article
  13. 13

    Profile of recombinant pro-urokinase given by intraarterial versus intravenous routes of administration in a canine thrombosis model by Burke, S E, Lubbers, N L, Nelson, R A, Wegner, C D, Cox, B F

    Published in Thrombosis and haemostasis (01-02-1999)
    “…Catheter-directed thrombolysis has gained increasing acceptance for the treatment of patients who present with vascular occlusion; however, intravenous…”
    Get more information
    Journal Article
  14. 14

    Fibrinolytic mechanism, biochemistry, and preclinical pharmacology of recombinant prourokinase by Credo, R B, Burke, S E

    “…The purpose of this review is to provide a biochemical characterization of recombinant prourokinase (r-ProUK [ABT-187]), including a description of its…”
    Get more information
    Journal Article
  15. 15

    Comparison of dose regimens for the administration of recombinant pro-urokinase in a canine thrombosis model by Burke, S E, Lubbers, N L, Nelson, R A, Henkin, J

    Published in Thrombosis and haemostasis (01-05-1997)
    “…Pro-urokinase represents an important addition to the array of thrombolytic drugs currently available for clinical use because of its high clot specificity but…”
    Get more information
    Journal Article
  16. 16

    Cardiotonic agents. 4. Synthesis and biological evaluation of N-substituted 2,4,4a,5-tetrahydro-3H-indeno[1,2-c]pyridazin-3-ones: rigid structures derived from CI-930 and analogs by Sircar, Ila, Duell, Bradley L, Cain, Michael H, Burke, Sandra E, Bristol, James A

    Published in Journal of medicinal chemistry (01-11-1986)
    “…Several N-substituted 3H-indeno[1,2-c]pyridazinones (1-23) and a benzo[h]cinnolinone (24), which were designed as rigid structural modifications of…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Effects of Zotarolimus (ABT-578), Sirolimus, Paclitaxel and Dexamethasone on Cytokine Production by Human Monocytes In Vitro by Li, Lanlan, Burke, Sandra E., Mack, Matthew M.

    Published in Blood (16-11-2005)
    “…Introduction: Percutaneous coronary intervention (PCI) and stenting are common therapies used to mitigate symptomatic coronary artery stenosis. These…”
    Get full text
    Journal Article
  19. 19

    Reduction of canine myocardial infarct size by CI-959, an inhibitor of inflammatory cell activation by Burke, S E, Wright, C D, Potoczak, R E, Boucher, D M, Dodd, G D, Taylor, Jr, D G, Kaplan, H R

    Published in Journal of cardiovascular pharmacology (01-10-1992)
    “…CI-959, a cell-activation inhibitor that prevents the formation of oxygen-derived free radicals by inflammatory cells, was studied to determine its effects on…”
    Get more information
    Journal Article
  20. 20

    Role of thromboxanes and prostaglandin endoperoxides in the pathogenesis of eicosanoid induced sudden death by Lefer, A M, Burke, S E, Smith, J B

    Published in Thrombosis research (01-11-1983)
    “…Arachidonic acid (1 mg/kg) or 9,11-azo PGH2 (35 micrograms/kg) injected intravenously into anesthetized rabbits results in sudden death characterized by a…”
    Get more information
    Journal Article